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Abstract
Background: The poor prognosis for glioblastoma patients is caused by the diffuse infiltrative growth pattern of the
tumor. Therefore, the molecular and cellular processes underlying cell migration continue to be a major focus of
glioblastoma research. Emerging evidence supports the concept that the tumor microenvironment has a profound
influence on the functional properties of tumor cells. Accordingly, substantial effort must be devoted to move from
traditional two-dimensional migration assays to three-dimensional systems that more faithfully recapitulate the
complex in vivo tumor microenvironment.
Methods: In order to mimic the tumor microenvironment of adult gliomas, we used adult organotypic brain slices as
an invasion matrix for implanted, fluorescently labeled tumor spheroids. Cell invasion was imaged by confocal or
epi-fluorescence microscopy and quantified by determining the average cumulative sprout length per spheroid.
The tumor microenvironment was manipulated by treatment of the slice with small molecule inhibitors or using
different genetically engineered mouse models as donors.
Results: Both epi-fluorescence and confocal microscopy were applied to precisely quantify cell invasion in this ex
vivo approach. Usage of a red-emitting membrane dye in addition to tissue clearing drastically improved epi-
fluorescence imaging. Preparation of brain slices from of a genetically engineered mouse with a loss of a
specific cell surface protein resulted in significantly impaired tumor cell invasion. Furthermore, jasplakinolide
treatment of either tumor cells or brain slice significantly reduced tumor cell invasion.
Conclusion: We present an optimized invasion assay that closely reflects in vivo invasion by the implantation
of glioma cells into organotypic adult brain slice cultures with a preserved cytoarchitecture. The diversity of
applications including manipulation of the tumor cells as well as the microenvironment, permits the investigation of rate
limiting factors of cell migration in a reliable context. This model will be a valuable tool for the discovery of the
molecular mechanisms underlying glioma cell invasion and, ultimately, the development of novel therapeutic strategies.
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Background
Glioblastoma is the most frequent and malignant primary
brain tumor, with a median survival of 12–15 months
after diagnosis. Despite extensive surgical resection,
chemo-, and radiotherapy, glioblastoma is still considered
incurable [1–3]. The diffuse infiltration of tumor cells into
adjacent healthy brain tissue is a major cause of treatment
failure, and so the characterization of signaling pathways
and effector molecules that drive glioblastoma invasion is a
major aim in glioblastoma research (for reviews see [4, 5]).
Most studies of tumor cell migration involve simple
and inexpensive two-dimensional methods like the in vitro
scratch and Boyden chamber/transwell assays. However,
recent studies have shown striking differences in protein
functions in two- and three-dimensional contexts [6–8].
Furthermore, in vivo tumor cells are embedded in a
three-dimensional matrix consisting of the extracellular
matrix (ECM) and multiple cell types, which can all
interact with tumor cells. Emerging evidence highlights
the substantial impact of these reciprocal interactions
within the tumor microenvironment on tumor cell in-
vasion [9], and therefore the requirement for an inva-
sion assay that closely mimics the environmental milieu
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that glioma cells encounter in vivo. Invading glioblastoma
cells follow distinct anatomical features called Scherer’s
structures. These include meninges and the subjacent
subarachnoid space, blood vessels, myelinated nerve fibers
and the extracellular space between neuronal or glial pro-
cesses in the brain parenchyma [10]. Taking into account
that glioblastoma cells migrate along these pre-existing
multicellular structures - that cannot simply be mimicked
by co-cultivation of the relevant cell types - we used orga-
notypic murine brain slice cultures as a three-dimensional
invasion matrix. Preserving essential features of the host
tissue such as neuronal connectivity, glial-neuronal inter-
actions and an authentic ECM, organotypic brain slice
cultures have mainly been used to study developmental,
structural and electrophysiological aspects of neuronal
circuits (for reviews see [11, 12]). Previously, these orga-
notypic cultures have also been presented as a novel tool to
examine the migratory behavior of ex vivo implanted tumor
cells [13–16]. However, the reported methods were based
on human brain slices, or the extent of invasion observed
was rather low and did not reflect the high infiltration
capacity of glioblastoma cells in vivo. Here, we present
an optimized and reproducible protocol to assess highly
infiltrating glioma cells in an adult murine brain slice.
In particular, we show that the usage of a membrane
dye with red-shifted fluorescence spectra and tissue
clearing results in greatly increased image quality. Fi-
nally, we present a selection of application examples,
including the treatment of tumor cells or the manipula-
tion of the tumor cell environment by pharmacological
inhibitors and the use of genetically modified mice as
brain slice donors. Knowledge gained from in vitro and
high-throughput approaches can be functionally validated
by this method, accentuating its value as link between in
vitro and animal studies.
Methods
Preparation of brain slices
6–8 week old C57Bl/6 wild-type or knockout mice were
euthanized, the brain was isolated and the cerebellum
removed with a scalpel. Using insect forceps the brain
was transferred to the vibratome (Leica VT1200 S) plat-
form and immediately fixed to this device by applying a
drop of superglue. The lateral short side of the brain was
placed facing the blade, in order to reduce mechanical
stress. 350 μm thick coronal slices were cut with a max-
imal speed of 0.2 mm/s. Up to three slices were gathered
per filter (Millipore #PICM03050). The transfer of the
slices was facilitated by a brush and addition of brain
slice medium on top of the filter. The brain slice medium
is composed of MEM (Sigma # M2279), 25% heat-
inactivated horse serum (Life Technologies # 26050070),
25 mM HEPES (Sigma # H0887-100 mL), 1 mM L- glu-
tamine (Sigma, # G7513), 5 mg/ml glucose (Sigma #
G8769), 100 U/ml penicillin/streptomycin (Sigma #
P4333). For cultivation at 37 °C and 5% CO2 the
medium was removed from the filter and 1 ml of fresh
brain slice medium was added below. The medium was
refreshed after 18-24 h and then every other day. Brain
slices were cultivated air-exposed. To prevent dehydra-
tion the tissue was moistened with a drop of medium
every day, and remaining excess medium removed. Al-
though the brain slices can be cultivated for at least
one week, experiments were performed at d2 and, due
to the high migratory capacity of glioma cells, termi-
nated on d4.
Preparation of fluorescently labeled spheroids
Murine (SMA560) and human (LN319; U87MG; U251MG)
glioma cell lines cultivated in serum-containing medium
(DMEM, Sigma # D5671; 10% FBS, Sigma # F7524; 2 mM
L-glutamine) were trypsinized and counted. 1 × 106 cells/ml
PBS were incubated with 5 μl lipophilic dye DiD (1 mg/ml
in DMSO, Biotium #60014) or 5 μl DiI (Biotium # 30022)
for 30 min at 37 °C. After two washing steps 500 cells/well
were seeded in a flat-bottom 96-well plate coated with 50 μl
low melt agarose (Genaxxon # M3049.0010; 1% in PBS).
SMA560 and U87MG spheroids were cultivated in
serum-containing DMEM medium, whereas the spheroid
formation of LN319 and U251MG required cultivation in
serum-free neurobasal medium (Thermo Fisher Scientific
# 10888022) containing B27 supplement (Thermo Fisher
Scientific # 17504044), 20 ng/ml of both EGF (Promokine
# C-60170) and FGFb (Promokine # C-60240), 2 μg/ml
heparin sodium salt (Sigma # H3149), 2 mM L-glutamine
and 1% penicillin/streptomycin (p/s; 100 U/ml).
Human and murine primary cells were cultivated as
spheroids in serum-free medium. Primary human cells
were kept in neurobasal medium, and primary murine cells
were cultivated in DMEM/F12 (Thermo Fisher Scientific #
21331020) medium containing N 2 supplement (Life
Technologies # 17502048), 20 ng/ml of both EGF and
FGFb, 2 mM L-glutamine and 1% penicillin/streptomycin
(100 U/ml). To generate spheroids for subsequent implan-
tations, cells were labeled as described above and seeded
in agarose-free U-bottom 96-well plates (500 cells/well;
Greiner # 650185).
Most glioma cell lines and primary cells we tested
formed spheroids under the described conditions. How-
ever, in some cases the protocol might have to be adjusted
to cultivation in neurobasal medium, or to the hanging
drop culture protocol. The last cultivation technique re-
quires medium supplementation with 20% methyl cellu-
lose. The single cell suspension is pipetted in drops of
20 μl on the inside of a dish which is then slowly inverted.
For generation of heterotypic spheroids, astrocytes
were isolated from 3 day old neonatal mice. Briefly,
brains were isolated and the meninges removed. Cortical
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tissue was ground on a 70 μm cell strainer with a glass
pestle. After three washes, cells were cultured in DMEM
(10% FBS, 2 mM L-glutamine and 1% p/s) on poly-lysine-
coated culture vessels. After a cultivation period of at least
10 days astrocytes were used for co-implantation experi-
ments. Astrocytes were labeled with DiI and co-cultivated
as heterotypic multicellular spheroids with DiD labeled
murine SMA560 glioma cells line in a ratio of 3:2 in
agarose coated 96-well plates for two days.
Due to the different growth rates of the tumor cells
used in the experiments and the difficulty of precisely
measuring the number of cells in an established spheroid,
we seeded a fixed number of 500 cells and implanted the
tumor cell spheroids when they reached a diameter of
approximately 150 μm.
The murine cell line SMA560 was provided by Prof.
Michael Platten (Department of Neurology, University
Heidelberg). The human cell lines LN319 and U251 were
provided by Prof. Wolfgang Wick (University Hospital
Heidelberg), and Prof. Michael Weller (Department of
Neurology, University Zurich) provided the human cell
line U87MG. Human and murine primary glioblastoma
cultures were generated in our laboratory.
Tumor cell and brain slice treatment with jasplakinolide
500 DiD labeled SMA560 glioma cells were seeded in
spheroid-forming conditions per well of a 96-well plate. 18 h
prior to implantation, spheroids or brain slices were
treated with 1 μM jasplakinolide (Cayman #11705) or
DMSO (Sigma # 41639-100ML). 24 h after implantation,
brain slices were fixed and imaged by confocal microscopy.
Cell viability in vitro was measured with trypan blue
staining (Sigma # 93595-50ML).
Spheroid implantation
8–10 spheroids per brain slice were manually implanted
using a blunt Hamilton syringe (701 N; 10 μl; 26 s/51/3)
and a binocular microscope. For this purpose, a single
spheroid was aspirated in a maximum volume of 0.5 μl
and implanted by release of the total volume into the tis-
sue. This procedure was repeated until 8–10 spheroids
were implanted along the cortex (see Fig. 1 for implant-
ation sites). There are several factors that are essential
for maximum invasion. Most important in this context
is proper implantation of the spheroids. It might help
to completely penetrate through the tissue to the filter
to estimate its depth; however, it is crucial to not re-
lease the spheroid onto the filter. The spheroid must be
implanted within the tissue, as release of the spheroid
below or on top of the brain tissue will not result in
tumor cell invasion but in proliferation or in some cases in
collective migration along the tissue surface. Furthermore,
tissue integrity is an essential factor for correct implant-
ation. Dehydration of brain slices impedes penetration of
the tissue with the needle tip, as the tissue surface becomes
too rigid. Conversely, excessive immersion of the brain
slice in medium results in tissue degeneration and disinte-
gration upon penetration with the needle tip. Thus, we
recommend moistening the brain slices every other
day, followed by removal of excessive medium. If these
instructions are carefully followed, a successful im-
plantation rate of at least 80% can be achieved.
Following implantation, medium was refreshed and
the slices cultivated at 37 °C and 5% CO2. Experiments
were terminated 2d after implantation unless otherwise
stated. For fixation brain slice medium was removed and
1 - 2 ml 4% PFA added on top of the filter for 2 h at RT
Fig. 1 Work flow of the ex vivo invasion assay based on organotypic brain slice cultures. Schematic representation of the individual protocol steps.
Immunohistochemistry staining shows MBP pattern of an adult murine brain slice cultivated for four days, arrows indicate implantation sites, scale
bar 1 mm
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or o/n at 4 °C. Fixed slices were transferred with a spat-
ula from the filter into a new 6-well plate containing
2 ml PBS/well. Although the slices can be stored in the
parafilm-sealed plate for at least three months in the
dark at 4 °C, slices were imaged by epi-fluorescence or
confocal microscopy as soon as possible.
Tissue clearing
To obtain high quality epi-fluorescence microscopy im-
ages, autofluorescent brain slices were cleared according
to the SeeDB protocol [17]. After incubation in 20% clear-
ing solution for 4-8 h in the dark with gentle shaking, the
clearing solution was changed to 40% and subsequently
60% clearing solution each for 4-8 h. Slices were sequen-
tially incubated in 80%, 100% and 115% clearing solution
o/n. As clearing solutions of 100% and 115% tend to crys-
talize, incubation steps were performed in a humid cham-
ber. Cleared slices were stored in the 115% clearing
solution in a dark humid chamber at RT. All clearing solu-
tions contain 0,5% α-thioglycerol (Sigma # M1753) and
the above given wt/vol percentage of (D-) fructose (Sigma
# F0127).
Imaging and quantification of invasion
For epi-fluorescence imaging the slices were kept in 6-well
plates containing PBS or, if the slices had been cleared,
115% clearing solution. For confocal imaging slices were
transferred with a spatula onto an object slide and loosely
covered with a coverslip.
Z-stack images were transformed to a maximum pro-
jection image by using ImageJ [18]. Image quality was
optimized by adjusting brightness, contrast and gamma.
Migratory cells were visible as spikes emerging from the
bulk of the spheroids that had been formed by cells es-
tablishing an infiltration path. These invasion sprouts
were traced from the center of the mass to the tip using
the freehand tool. The radius of the spheroid body (if not
determinable spheroid body radius from d0) was sub-
tracted from the measured sprout length. Subsequently,
we calculated the average cumulative sprout length by
adding up the length of all sprouts of a spheroid and
dividing this sum by the number of analyzed spheroids.
This statistic integrates sprout length and the number
of sprouts to estimate the migratory capacity of the cells.
Calculation of the cumulative sprout length is a common
tool in angiogenesis research, where it is used as reliable
quantification of cell movement and proliferation in a
three-dimensional environment [19–22].
Statistical analysis
Welch’s t-test was performed to evaluate the difference
between the cumulative sprout lengths of experimental
groups. Differences in the grade of invasion were con-
sidered significant if p < 0.05. Bonferroni correction of
p-values was applied for multiple comparisons (in par-
ticular, comparison of jasplakinolide treated cells, cells
implanted in jasplakinolide treated slices and control cells).
Immunohistochemistry
4d after brain slice preparation the tissue was fixed and
pre-embedded in 2% agar (Carl Roth # 5210.3)- 2.5%
gelatin (Merck Millipore # 1040700500; in PBS) without
sponge pads and subsequently processed for paraffin em-
bedding. 4-6 μm thick sections were stained according to
standard immunohistochemistry protocols. The antibodies
used were specific for: glial fibrillary acidic protein (GFAP)
(Biolegend # 644701; diluted 1:500), laminin (Progen
Biotech # 10765; diluted 1:200), myelin basic protein (MBP)
(Abcam # 7349; diluted 1:200) and ionized calcium-binding
adapter molecule 1 (Iba1) (Wako # 019–19,741; diluted
1:500).
Results
Adult slice cultures retain cytoarchitecture of the brain
The majority of previous publications utilized brain slices
from perinatal donors that show a high degree of resist-
ance to mechanical trauma during slice preparation [23].
However, as high grade gliomas are most common among
adult patients, we used adult mice with a fully developed
brain, including completed myelination, as donors for the
preparation of brain slices. To determine whether the
cytoarchitecture is preserved, we performed immunohis-
tochemical staining on adult brain slices embedded 4 days
after slicing. We observed that blood vessels and myelin-
ated fiber tracts were present and morphologically intact;
astrocytes (GFAP) and microglia (Iba1) were slightly ac-
tivated within the brain slice, presumably induced by
the mechanical trauma of cutting (Fig. 2). In contrast to
the survival of astrocytes, microglia and endothelial
cells, neuronal survival in brain slices has been reported
as a major challenge, especially for slices prepared from
adult donors [24]. This is partly attributed to the fact
that neuronal cell death is induced by axotomy during
the process of tissue slicing. However, the structure of
myelinated nerve tracts remains intact and provides the
same structural surfaces glioma cells encounter in vivo.
Taken together, we confirm that the cytoarchitecture of
the adult murine brain is retained in the slices which,
thus, represent a suitable three-dimensional matrix to
study glioma cell invasion.
Assessment of invasive capacity
To demonstrate that our ex vivo invasion assay protocol
allows a high degree of glioma cell invasion, we manually
implanted a panel of DiD labeled human and murine
glioma spheroids into adult brain slices that had been
adapted to in vitro conditions for 2 days. 48 h after im-
plantation we fixed the slices and performed confocal
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imaging. As depicted in Fig. 3 all types of implanted gli-
oma cells invaded strongly into the surrounding tissue.
These observations suggest that the invasive capacity of
different tumor cells can be reliably assessed and com-
pared using this ex vivo invasion assay protocol.
DiD labeling of tumor cells and optional tissue clearing
enables high-contrast imaging
Although previous studies have used ectopic GFP expres-
sion or the carbocyanine dye DiI for membrane labeling
and tracing of cell invasion [13, 14, 16], we experienced
high autofluorescence of the brain slice and a poor con-
trast between tissue and tumor cells when imaged with
short excitation/emission wavelengths. To reduce this
autofluorescent background we used the lipophilic carbo-
cyanine dye DiD, an analog of DiI with markedly red-
shifted fluorescence excitation and emission spectra. As
autofluoresence decreases dramatically at longer wave-
lengths, DiD labeling resulted in strikingly sharper images
compared to DiI (Fig. 4) and is moreover preferable for
live cell imaging applications due to reduced photodama-
ging effects. To further improve epi-fluorescence imaging
we cleared the brain tissue according to the SeeDB proto-
col [17]. As shown in Fig. 5 the quality of epifluorescence
images of cleared brain slices was dramatically improved
when compared to uncleared tissue. Taken together, our
results show that tumor cell labeling with the carbo-
cyanine dye DiD and brain slice clearing produce
high-contrast epi-fluorescence images, representing a
comparable alternative to confocal microscopy.
Brain slices prepared from genetically engineered mice are
suitable to study the stromal impact on tumor cell invasion
The influence of the microenvironment on the invasive
behavior of tumor cells has been increasingly recognized.
To illustrate that the ex vivo invasion assay enables the
study of tumor cell/microenvironment interactions, we
used brain slices prepared from a genetically engineered
mouse with a global loss of a cell surface protein. We
observed a substantial reduction in tumor cell invasion
upon spheroid implantation in knockout compared to
control wild-type brain slices (Fig. 6a-c). Thus, our results
demonstrate the suitability of this assay to study the im-
pact of stromal components on tumor cell invasion by
using brain slices from genetically engineered mice.
Heterotypic spheroids allow direct comparison of different
cell types and their mutual influence on invasion
To examine the mutual influence of different cell types
on their invasive properties, we performed implantations
Fig. 2 Organotypic brain slice cultures maintain characteristic features of adult brain tissue. Immunohistochemical staining of 4-6 μm sections of
adult murine brain slices (prepared from 350 μm vibratome sections and cultivated for four days) compared to 4-6 μm sections of whole adult
murine brains. Note the comparable patterns of blood vessels, as indicated by laminin, and myelinating oligodendrocytes, as indicated by MBP
staining. We observed slight activation of astrocytes (GFAP) and microglia (Iba1) within the brain slice, presumably induced by the mechanical
trauma of vibratome cutting. White scale bars 100 μm, black scale bars 1 mm
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of heterotypic spheroids composed of tumor cells and
other cell types differentially labeled with fluorescent
dyes. In heterotypic spheroids generated from tumor
cells and reactive astrocytes, we observed migration of
both cell types (Fig. 6d) without identifying one cell
type as the leading cell. Similarly, this method allows
for the co-cultivation of control and genetically modi-
fied tumor cells, i.e. harboring gain or loss of specific
proteins, and direct comparison of their invasive
behavior.
The ex vivo invasion assay as a tool to identify small
molecules affecting invasion
Finally, we evaluated whether the system is suitable for
small molecule treatment for the testing of cell invasion
modulating compounds. In our experimental setting the
drug can be applied either directly to the tumor cells or
to the environment. As a proof of principle, we treated
tumor spheroids before implantation with jasplakinolide,
a known inhibitor of migration [25, 26]. Previously, an
inhibitory effect of 1 μM jasplakinolide on actin
f
a
d
cb
e
Fig. 3 Improved ex vivo cell invasion assay. Representative confocal images of DiD labeled primary glioma cells (human (a), murine (b)) and established
glioma cell lines (murine SMA560 (c) and human LN319 (d), U87MG (e) and U251MG (f)) implanted in adult brain slice cultures. Images were acquired at
d0 (top) and d2 (bottom). Scale bars 100 μm, image quality was optimized by adjustment of brightness, contrast and gamma
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depolymerization and thus cell migration had been de-
scribed [26, 27]. Consistent with this, we observed signifi-
cantly less tumor cell invasion upon tumor cell treatment
with 1 μM jasplakinolide for 18 h (Fig. 6e, f, h). Import-
antly, cell death was not induced under these conditions
(Fig. 6i). We obtained similar results when treating the
brain slice with 1 μM jasplakinolide 18 h prior to implant-
ation (Fig. 6g). This result highlights the application of our
method to drug discovery and preclinical evaluation, by
permitting the selection of compounds affecting tumor
cell invasion prior to in vivo testing.
a b
c d
Fig. 4 Improved image quality by DiD labeling and confocal imaging.
Representative pictures of epi-fluorescence (a, c) and confocal
microscopy (b, d). Usage of DiD (c, d) improves picture quality
compared to DiI labeling of SMA560 cells (a, b). Scale bars 100 μm,
image quality was optimized by adjustment of brightness, contrast
and gamma
a b
Fig. 5 Improved epi-fluorescence microscopy after tissue clearing. DiD
labeled LN319 cells imaged by epi-fluorescence microscope before (a)
and after tissue clearing (b). Scale bars 100 μm, image quality was
optimized by adjustment of brightness, contrast and gamma
a b
c d
e f g
h i
Fig. 6 Multiple applications of the ex vivo invasion assay. Representative
confocal images, scale bars 100 μm, image quality was optimized by
adjustment of brightness, contrast and gamma. a-c Brain slices of
genetically modified mice as a tool to modulate the microenvironment.
Human glioma cell line LN319 implanted in a wild-type and b
knockout brain slices. The deletion of a specific cell surface protein
in the microenvironment significantly inhibits tumor cell invasion
as quantified in (c). Error bars represent 95% confidence interval,
(A) n = 7; (B) n = 5; **p < 0.001, Welch’s t-test. d Co-implantation of
different cell types. Reactive astrocytes (pseudocolored in green,
DiI labeled) and the murine glioma cell line SMA560 (red, DiD labeled)
were co-cultured in a ratio of 3:2 as heterotypic multicellular spheroids
and implanted in a wild-type brain slice. e-i The ex vivo invasion assay
as a tool to identify invasion modulating compounds. 500 SMA560
glioblastoma cells were seeded per well to induce spheroid growth.
18 h prior to implantation, spheroids or brain slices were treated with
1 μM jasplakinolide. 24 h after implantation, brain slices were fixed and
imaged by confocal microscopy. In contrast to e the highly invasive
control-treated SMA560, f the treatment of the tumor cells or g brain
slices with jasplakinolide significantly reduced their ability to invade
without inducing cell death as examined by trypan blue staining (i). h
Quantification of invasion. Error bars show 95% confidence interval,
e n = 12; f, g n = 7; i n = 3; **p < 0.001; ***p ≤ 0.0001; Welch’s t-test,
p-values Bonferroni corrected
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Discussion
In the past decades tumor cell invasion has primarily
been assessed by inexpensive and rapid two-dimensional
assays. However, these cell culture models are very lim-
ited in their power to accurately predict the effect of
proteins or small molecules on cell invasion in vivo,
probably due to functional differences of proteins between
two- and three-dimensional migration and the absence of
environmental influences [28]. Although animal models
are thought to represent the most reliable method of inves-
tigating cell invasion, they involve not only high cost but
also ethical and technical concerns. The laborious and time
inefficient application of mouse models is especially disad-
vantageous for co-clinical and personalized treatment stud-
ies that rely on a rapid read out and the exclusion of false-
positive candidate compounds identified by conventional
two-dimensional assays [29]. This has resulted in attempts
to bridge the gap between over-simplified cell culture ap-
proaches and the more meaningful, but inefficient, in vivo
models with reproducible ex vivo techniques. The current
state of the art to mimic the natural environment of glioma
cells are organotypic brain slice cultures that can be
cultivated ex vivo for several days to weeks without
considerable loss of their cytoarchitecture. Retaining
their physiological structure, brain slices provide an op-
timal three-dimensional matrix for ex vivo invasion as-
says. To our knowledge, mostly perinatal donors have
been used for the preparation of organotypic brain slices
due to their high mechanical and ischemic resistance.
However, in rodents the ECM is substantially remodeled
starting from 2 weeks after birth. This remodeled and thus
significantly firmer ECM is subsequently maintained
throughout adulthood [30]. Similarly, myelination of
nerve fibers occurs predominantly postnatally and can
be extended to adulthood [31]. Hence, absent or incom-
plete myelination and the immature and loose extracellu-
lar matrix are profound differences between neonatal and
mature adult brain tissue. In order to reflect the age re-
lated disease of adult glioma, we decided to use adult
brain slices that exhibit a mature myelination pattern and
ECM composition.
While there are previous reports that use organotypic
brain slices for tumor cell invasion assessment, we still
lack a simple, standardized, and reproducible protocol
that allows its application in basic and preclinical research.
Various approaches for the co-cultivation of tumor cells
and slices and the measurement of cell invasion have been
published. For brain metastasis research, tumor cells have
been seeded in a matrigel plug adjacent to the brain slice
in order to investigate interactions between cancer and
glial cells by fluorescence microscopy [32]. However,
this model is unsatisfactory when used to examine the
invasion of primary brain tumor cells, as they arise and
migrate within the brain tissue and moreover do not
encounter an environment comparable to matrigel. Other
publications have developed this approach by seeding
single cells on top of the slices [33]. However, we see
disadvantages in this technique, as it is disturbed by the
diffusion of single cells after seeding and requires life
cell imaging, preferably by an upright confocal micro-
scope, which is not universally available. Moreover, we
have observed reduced invasion when the tumor cells
were seeded on top instead of within the tissue, as the
cells migrate on the slice surface instead of efficiently
penetrating the tissue. In contrast, we implant tumor
cells as spheroids within the tissue in order to position
them at a specific location of the brain slice and to pro-
vide a comparable starting point for the assay. Indeed,
other publications have reported this approach; however,
they show a low grade of invasion that does not reflect the
aggressive infiltration observed in patients [13, 15, 16].
Following our protocol, we could observe strong invasion
in a panel of human and murine glioma cell lines as well
as primary cells. Moreover, we could improve the imaging
quality of implanted tumor cells using DiD, which drastic-
ally reduces autofluorescence compared to the commonly
applied DiI. Epi-fluorescence microscopy was further opti-
mized by tissue clearing according to the SeeDB protocol
[17]. Thus, we have generated an optimized and standard-
ized protocol that acts as the basis of a set of functional
applications, some of which we describe here. The pos-
sibility of specifically manipulating either one or both
compartments involved in tumor cell migration, the
microenvironment and the tumor cells themselves, and
to monitor the consequences of the manipulation on
tumor cell invasion is a major advantage of this improved
protocol. Here, we demonstrate the flexibility of the proto-
col by manipulating the microenvironment with exogenous
small molecule treatment or using genetically modified
mice as donors for the organotypic brain slice cultures.
This allows the investigation of the effects of global inacti-
vation of a gene or gene product of interest, as well as cell
type-specific deletion or overexpression, depending on the
mouse model used. In addition, this assay is suitable for
direct manipulation of the tumor cells themselves by gain-
or loss-of-function approaches. Consequently, the combin-
ation of both strategies is a powerful tool i) to identify crit-
ical factors in tumor cells and their putative interaction
partners in the tumor microenvironment and ii) to dissect
their mode of action in tumor cell invasion, ultimately
yielding potential novel targets for brain tumor therapy.
Conclusion
As growing evidence suggests the tumor microenvir-
onment as a key factor in tumor cell invasion, we opti-
mized an ex vivo invasion assay that can reliably and
quantitatively measure glioma cell movement in an
environment that more accurately recapitulates the
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physiological state in vivo. The functional applications
described demonstrate the power and versatility of this
method as an advance over previous work, and will en-
courage the use of more relevant models than traditional
two-dimensional migration assays.
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